A
Alexander I. Gray
Researcher at Strathclyde Institute of Pharmacy and Biomedical Sciences
Publications - 296
Citations - 7233
Alexander I. Gray is an academic researcher from Strathclyde Institute of Pharmacy and Biomedical Sciences. The author has contributed to research in topics: Eriostemon & Premna. The author has an hindex of 41, co-authored 292 publications receiving 6648 citations. Previous affiliations of Alexander I. Gray include University of Strathclyde & Netaji Subhas Institute of Technology.
Papers
More filters
Journal ArticleDOI
Chemotaxonomic significance of coumarins to the monotypic genus Psilopeganum
Peter G. Waterman,Alexander I. Gray,Yun-Cheung Kong,Paul Pui-Hay But,Kam-Hung Ng,Hung-Ta Chang +5 more
TL;DR: A sample of the above ground parts of Psilopeganum sinense (Rutaceae) has yielded five coumarins, the common furocoumarins bergapten, xanthotoxin and isopimpinellin, and two 3-prenylated compounds, the furoCoumarin chalepensin and the simple coumarin 3-(1,1-dimethylallyl)herniarin.
Journal ArticleDOI
Milonine, an 8,14‐Dihydromorphinandienone Alkaloid from Leaves of Cissampelos sympodialis
M. R. De Freitas,J. Lima De Alencar,Emídio V. L. da-Cunha,José Maria Barbosa-Filho,Alexander I. Gray +4 more
Journal ArticleDOI
Formulation and evaluation of nanosized hippadine-loaded niosome: Extraction and isolation, physicochemical properties, and in vitro cytotoxicity against human ovarian and skin cancer cell lines
Mohammad A. Obeid,Comfort Alicha Ogah,Celina Ogah,Olusegun S. Ajala,Alexander I. Gray,Valerie A. Ferro +5 more
Patent
Dendrimeres utilises pour une administration ciblee
Alexander I. Gray,Avril Anstruther Munro,AG Schatzlein,Ijeoma F. Uchegbu,Bernd H. Zinselmeyer +4 more
TL;DR: In this article, a trait a des dendrimeres cationiques, destines a administrer a un organisme mammalien des molecules bioactives, notamment des molecules polynucleotidiques, des peptides ainsi que des polypeptides and/or des agents pharmaceutiques.
Journal ArticleDOI
Dataset on the kinetics of the inhibition of PTP1B by the flavonoids and pheophytin A from Allophylus cominia.
Dima Semaan,John O. Igoli,John O. Igoli,Louise C. Young,E. Marrero,Alexander I. Gray,Edward G. Rowan +6 more
TL;DR: The data presented in this article are related to the research article under the title “in vitro anti-diabetic activity of flavonoids and pheophytins from Allophylus cominia Sw. on PTP1B, DPPIV, alpha-glucosidase and alpha-amylase enzymes” (Semaan et al., 2017).